N-arylation of 3-alkoxypyrazoles, the case of the pyridines
摘要:
In the course of a research program focused on the preparation of libraries of new chemical entities derived from 3-alkoxypyrazoles, we studied their N-pyridylation using 2, 3 or 4-bromopyridines This was achieved using Cristau and Taillefer copper-catalyzed arylation method and mostly led to the 3-alkoxy-1H-pyrazol-1-yl pyridine isomer along with lesser amount of the alternative 5-alkoxy-1H-pyrazol-1-yl pyridine The structures of these isomers were often established via their chemical tansformations and sometimes recourse to unambiguous synthetic routes for comparison purposes The alternative use of 2-fluoropyridine-based arylation was also investigated and lifted some of the limitations encountered in the course of this study (C) 2010 Elsevier Ltd All rights reserved
N-arylation of 3-alkoxypyrazoles, the case of the pyridines
摘要:
In the course of a research program focused on the preparation of libraries of new chemical entities derived from 3-alkoxypyrazoles, we studied their N-pyridylation using 2, 3 or 4-bromopyridines This was achieved using Cristau and Taillefer copper-catalyzed arylation method and mostly led to the 3-alkoxy-1H-pyrazol-1-yl pyridine isomer along with lesser amount of the alternative 5-alkoxy-1H-pyrazol-1-yl pyridine The structures of these isomers were often established via their chemical tansformations and sometimes recourse to unambiguous synthetic routes for comparison purposes The alternative use of 2-fluoropyridine-based arylation was also investigated and lifted some of the limitations encountered in the course of this study (C) 2010 Elsevier Ltd All rights reserved
Alkoxypyrazoles and the process for their preparation
申请人:Institut Pasteur
公开号:EP2151433A1
公开(公告)日:2010-02-10
The present invention relates to a alkoxypyrazoles preparation process, and new alkoxypyrazole compounds.
本发明涉及一种烷氧基吡唑的制备方法,以及新的烷氧基吡唑化合物。
Pyrazole derivatives as dihydroorotate dehydrogenase (DHODH) inhibitors
申请人:INSTITUT PASTEUR
公开号:EP2929883A1
公开(公告)日:2015-10-14
The present invention relates to compounds of formula (I) for their use in the treatment and/or prevention of auto-immune or auto-immune related diseases, cancer, viral infections, and central nervous system diseases and disorders, by inhibiting human dehydroorate dehydrogenase (DHODH):
Wherein R1, R2, R3, R4 and Ar are as defined in claim 1.
本发明涉及式(I)化合物,通过抑制人脱氢脱氢酶(DHODH),用于治疗和/或预防自身免疫或自身免疫相关疾病、癌症、病毒感染以及中枢神经系统疾病和失调:
其中 R1、R2、R3、R4 和 Ar 如权利要求 1 所定义。
[EN] NEW ALKOXYPYRAZOLES<br/>[FR] NOUVEAUX ALCOXYPYRAZOLES
申请人:PASTEUR INSTITUT
公开号:WO2010015657A2
公开(公告)日:2010-02-11
The present invention relates to a alkoxypyrazoles preparation process, and new alkoxypyrazoles compounds.
N-arylation of 3-alkoxypyrazoles, the case of the pyridines
作者:Sandrine Guillou、Frédéric J. Bonhomme、Di Betina Chahine、Olivier Nesme、Yves L. Janin
DOI:10.1016/j.tet.2010.02.032
日期:2010.4
In the course of a research program focused on the preparation of libraries of new chemical entities derived from 3-alkoxypyrazoles, we studied their N-pyridylation using 2, 3 or 4-bromopyridines This was achieved using Cristau and Taillefer copper-catalyzed arylation method and mostly led to the 3-alkoxy-1H-pyrazol-1-yl pyridine isomer along with lesser amount of the alternative 5-alkoxy-1H-pyrazol-1-yl pyridine The structures of these isomers were often established via their chemical tansformations and sometimes recourse to unambiguous synthetic routes for comparison purposes The alternative use of 2-fluoropyridine-based arylation was also investigated and lifted some of the limitations encountered in the course of this study (C) 2010 Elsevier Ltd All rights reserved